Vital Chemtech Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
VITAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vital Chemtech Limited reported audited standalone financial results for Q4 and year ended March 31, 2026. Standalone revenue from operations grew to Rs 3,074 Lakhs for Q4 and Rs 10,526 Lakhs for full year, representing approximately 20% YoY growth. However, standalone PAT declined to Rs 895 Lakhs from Rs 1,692 Lakhs in the prior year. The auditor issued an unmodified (clean) opinion on both standalone and consolidated results. The company also appointed R J & Associates as Cost Auditor for FY27. Consolidated results include two subsidiaries (Vital Alkoxide Private Limited and Vital Synthesis Limited) with consolidated PAT of Rs 84 Lakhs for FY26.
Revenue growth of ~20% YoY is positive, but the significant decline in standalone PAT (down ~47%) raises profitability concerns. The clean audit opinion provides assurance on financial statement reliability. Shareholders should monitor the PAT decline trend and margin compression.